{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T10:42:38Z","timestamp":1722681758157},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T00:00:00Z","timestamp":1250208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The objective of this research was to evaluate data from a randomized clinical trial that tested injectable diacetylmorphine (DAM) and oral methadone (MMT) for substitution treatment, using a multi-domain dichotomous index, with a Bayesian approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Sixty two long-term, socially-excluded heroin injectors, not benefiting from available treatments were randomized to receive either DAM or MMT for 9 months in Granada, Spain. Completers were 44 and data at the end of the study period was obtained for 50. Participants were determined to be responders or non responders using a multi-domain outcome index accounting for their physical and mental health and psychosocial integration, used in a previous trial. Data was analyzed with Bayesian methods, using information from a similar study conducted in The Netherlands to select a priori distributions. On adding the data from the present study to update the a priori information, the distribution of the difference in response rates were obtained and used to build credibility intervals and relevant probability computations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the experimental group (n = 27), the rate of responders to treatment was 70.4% (95% CI 53.2-87.6), and in the control group (n = 23), it was 34.8% (95% CI 15.3-54.3). The probability of success in the experimental group using the <jats:italic>a posteriori<\/jats:italic> distributions was higher after a proper sensitivity analysis. Almost the whole distribution of the rates difference (the one for diacetylmorphine minus methadone) was located to the right of the zero, indicating the superiority of the experimental treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present analysis suggests a clinical superiority of injectable diacetylmorphine compared to oral methadone in the treatment of severely affected heroin injectors not benefiting sufficiently from the available treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration<\/jats:title>\n            <jats:p>Current Controlled Trials ISRCTN52023186<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-10-70","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T18:13:56Z","timestamp":1250273636000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index"],"prefix":"10.1186","volume":"10","author":[{"given":"Emilio","family":"Perea-Milla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Carlos Silva","family":"Ay\u00e7aguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Carles March","family":"Cerd\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Gonz\u00e1lez","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rivas-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Danet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Romero","family":"Vallecillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,14]]},"reference":[{"key":"358_CR1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","volume":"343","author":"RE Johnson","year":"2000","unstructured":"Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE: A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000, 343: 1290-1297. 10.1056\/NEJM200011023431802.","journal-title":"N Engl J Med"},{"key":"358_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP: Role of maintenance treatment in opioid dependence. Lancet. 1999, 353: 221-226. 10.1016\/S0140-6736(98)05356-2.","journal-title":"Lancet"},{"key":"358_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000068811","volume":"9","author":"F G\u00fcttinger","year":"2003","unstructured":"G\u00fcttinger F, Gschwend P, Schulte B, Rehm J, Uchtenhagen A: Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur Addict Res. 2003, 9: 73-79. 10.1159\/000068811.","journal-title":"Eur Addict Res"},{"key":"358_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D: Heroin-assisted treatment for opioid dependence: Randomised controlled trial. Br J Psychiatry. 2007, 191: 55-62. 10.1192\/bjp.bp.106.026112.","journal-title":"Br J Psychiatry"},{"key":"358_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","volume":"358","author":"J Rehm","year":"2001","unstructured":"Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A: Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet. 2001, 358: 1417-1423. 10.1016\/S0140-6736(01)06529-1.","journal-title":"Lancet"},{"key":"358_CR6","volume-title":"N Eng J Med","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT: Diacetylmorphine vs. methadone for the treatment of opioid addiction. N Eng J Med. 2009,"},{"key":"358_CR7","first-page":"245","volume":"5","author":"M Killias","year":"1996","unstructured":"Killias M, Uchtenhagen A: Does medical heroin prescription reduce delinquency among drug-addicts? On the evaluation of the Swiss heroin prescription projects and its methodology. Studies on Crime and Crime Prevention. 1996, 5: 245-256.","journal-title":"Studies on Crime and Crime Prevention"},{"key":"358_CR8","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-3-318-00432-8","volume-title":"Cost-benefit analysis of heroin maintenance treatment. Medical prescription of narcotics","author":"F Gutzwiller","year":"2000","unstructured":"Gutzwiller F, Steffen T: Cost-benefit analysis of heroin maintenance treatment. Medical prescription of narcotics. 2000, Basle: Karger"},{"key":"358_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","volume":"330","author":"MG Dijkgraaf","year":"2005","unstructured":"Dijkgraaf MG, Zanden van der BP, de Borgie CA, Blanken P, van Ree JM, Brink van den W: Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ. 2005, 330: 1297-10.1136\/bmj.330.7503.1297.","journal-title":"BMJ"},{"key":"358_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","volume":"327","author":"W van den Brink","year":"2003","unstructured":"Brink van den W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ. 2003, 327: 310-10.1136\/bmj.327.7410.310.","journal-title":"BMJ"},{"key":"358_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","volume":"31","author":"JC March","year":"2006","unstructured":"March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F, PEPSA team: Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat. 2006, 31: 203-211. 10.1016\/j.jsat.2006.04.007.","journal-title":"J Subst Abuse Treat"},{"key":"358_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s11524-007-9198-y","volume":"84","author":"B Fischer","year":"2007","unstructured":"Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, Strang J, Brink van den W: Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics. J Urban Health. 2007, 84: 552-562. 10.1007\/s11524-007-9198-y.","journal-title":"J Urban Health"},{"key":"358_CR13","volume-title":"Utrecht: Central Committee on the Treatment of Heroin Addicts","author":"W van den Brink","year":"2002","unstructured":"Brink van den W, Hendriks VM, Blanken P, Huijsman IA, van Ree JM: Medical co-prescription of heroin: Two randomized controlled trials. Utrecht: Central Committee on the Treatment of Heroin Addicts. 2002"},{"key":"358_CR14","volume-title":"Basic and clinical science of opioid addiction","author":"J Rehm","year":"2003","unstructured":"Rehm J: Scientific evaluations of opioid-assisted substitution treatment. Basic and clinical science of opioid addiction. Edited by: Kuntze MF, M\u00fcller-Spahn F, Ladewig D, Bullinger AH. 2003, Basel: Karger"},{"key":"358_CR15","first-page":"CD003410","volume-title":"Cochrane Database Syst Rev","author":"M Ferri","year":"2005","unstructured":"Ferri M, Davoli M, Perucci CA: Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev. 2005, CD003410-"},{"key":"358_CR16","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J: The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998, 93: 1857-1867. 10.1046\/j.1360-0443.1998.9312185711.x.","journal-title":"Addiction"},{"key":"358_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.2044-8260.1977.tb00241.x","volume":"16","author":"LR Derogatis","year":"1977","unstructured":"Derogatis LR, Cleary PA: Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol. 1977, 16: 347-356.","journal-title":"Br J Soc Clin Psychol"},{"key":"358_CR18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/bmj.317.7166.1151","volume":"317","author":"JM Bland","year":"1998","unstructured":"Bland JM, Altman DG: Bayesians and frequentists. BMJ. 1998, 317: 1151-1160.","journal-title":"BMJ"},{"key":"358_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/bmj.319.7208.508","volume":"319","author":"DJ Spiegelhalter","year":"1999","unstructured":"Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR: Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ. 1999, 319: 508-512.","journal-title":"BMJ"},{"key":"358_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.1995.03520350053028","volume":"73","author":"JM Brophy","year":"1995","unstructured":"Brophy JM, Joseph L: Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA. 1995, 73: 871-875. 10.1001\/jama.273.11.871.","journal-title":"JAMA"},{"key":"358_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2214\/ajr.184.4.01841057","volume":"184","author":"L Joseph","year":"2005","unstructured":"Joseph L, Reinhold C: Statistical inference for proportions. AJR Am J Roentgenol. 2005, 184: 1057-1064.","journal-title":"AJR Am J Roentgenol"},{"key":"358_CR22","volume-title":"Software for analysis of tabulated data","author":"EPIDAT 3.1","year":"2006","unstructured":"EPIDAT 3.1: Software for analysis of tabulated data. 2006, Pan American Health Organization. Xunta de Galicia"},{"key":"358_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1037\/10222-011","volume-title":"The Science of Prevention: methodological advances from alcohol and substance abuse research","author":"ML Dennis","year":"1997","unstructured":"Dennis ML, Lennox RI, Foss M: Practical power analysis for substance abuse health services research. The Science of Prevention: methodological advances from alcohol and substance abuse research. Edited by: Bryant KJ, Windle M, West SG. 1997, Washington, DC, American Psychological Association, 367-405."},{"key":"358_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(05)61034-3","volume":"365","author":"KF Schulz","year":"2005","unstructured":"Schulz KF, Grimes DA: Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005, 365: 1348-1353. 10.1016\/S0140-6736(05)61034-3.","journal-title":"Lancet"},{"key":"358_CR25","volume-title":"International Committee of Medical Journal Editors","author":"ICMJE","year":"2005","unstructured":"ICMJE: Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. 2005, http:\/\/www.icmje.org\/"},{"key":"358_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/archpsyc.1980.01780210035003","volume":"37","author":"RL Hartnoll","year":"1980","unstructured":"Hartnoll RL, Mitcheson MC, Battersby A, Brown G, Ellis M, Fleming P, Hedley N: Evaluation of heroin maintenance in controlled trial. Arch Gen Psychiatry. 1980, 37: 877-884.","journal-title":"Arch Gen Psychiatry"},{"key":"358_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","volume":"317","author":"TV Perneger","year":"1998","unstructured":"Perneger TV, Giner F, del Rio M, Mino A: Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ. 1998, 317: 13-18. 10.1186\/1477-7517-3-16.","journal-title":"BMJ"},{"key":"358_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7517-3-16","volume":"3","author":"DR Small","year":"2006","unstructured":"Small DR, Drucker E: Policy Makers Ignoring Science Scientists Ignoring Policy: The Medical Ethical Challenges of Heroin Treatment. Harm Reduct J. 2006, 3: 16-","journal-title":"Harm Reduct J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-10-70\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-70","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:14:19Z","timestamp":1630480459000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-10-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-10-70","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,14]]},"assertion":[{"value":"15 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"70"}}